Treatment of severe pulmonary blastomycosis with oral itraconazole: Case report

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1336-1337

  Ralph, Edward D ^a,b   Plaxton, William R ^b   Sharpe, Michael D ^b  

^a Division of Infectious Diseases   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ITRACONAZOLE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; BRONCHIECTASIS; CASE REPORT; HUMAN; IMMUNE DEFICIENCY; LIVER BIOPSY; LIVER TOXICITY; LUNG FUNCTION TEST; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPUTUM CULTURE;

ADMINISTRATION, ORAL; ADULT; ANTIFUNGAL AGENTS; BLASTOMYCOSIS; HUMANS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; MALE;

EID: 0033512475     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313459     Document Type: Article

References (5)

1. 1. Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis 1996; 22(Suppl 2):S102-11.
2. 2. Gill J, Sprenger H, Ralph ED, Sharpe MD. Hepatotoxicity possibly caused by amphotericin B. Ann Pharmacother 1999;33:683-5.
3. 3. Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993;329:1231-6.
4. 4. Clemons KV, Stevens DA. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Antimicrob Agents Chemother 1997;41:2026-8.
5. 5. Schutze GE, Hickerson SL, Fortin EM, et al. Blastomycosis in children. Clin Infect Dis 1996;22:496-502.